FDA Probes RSV Drug Safety; Why Some Cancers Shouldn’t Be Treated; New Mpox Strain

(MedPage Today) — Note that some links may require registration or subscription.
The FDA reportedly told drugmakers that approved monoclonal antibodies to protect infants against respiratory syncytial virus (RSV) would be subject to new safety…